Four growth drivers beyond patent for pharma companies like Sun Pharma, Sanofi Economic Times Ahead of the Pack: When launched in India in 2007, Dr Reddy's Reditux, a brand of cancer drug rituximab, was the first biosimilar of Roche's $6 billion cancer drug Rituxan anywhere in the world. Dr Reddy's has begun selling a biosimilar of rituximab in ... |
